Help Us Get to Work
Trump Has Ordered Another Major Reduction in the Workforce
Scott Jennings Silences CNN Panel by Reminding Them About Biden's War on the...
Trump Gave an Update on Whether the Philadelphia Eagles Will Be Coming to...
There's a Reason Why Progressives Fear Black People With Guns
Supreme Court Overturns Death Row Inmate Richard Glossip's Sentence and Conviction
REPORT: James Comey Conducted Secret 'Honeypot' Investigation Into Trump Campaign
Anti-Gun Judge Hits Brooklyn Man With 10-Year Sentence for Building Firearms—Now He’s Figh...
Rewriting History in Real Time: Jake Tapper Book to Look Into Coverup of...
How the Left Lies With Statistics
Trump Wants the Keystone XL Pipeline to Restart 'Now'. There's Just One Problem.
Arrest the Anti-ICE Activists Interfering in Federal Operations
Only the CDU Can Save Germany
Here's Who Is in Charge of DOGE
This Democrat Governor Will Pull Funding From Cities That Do Not Tackle Homelessness
Tipsheet

The Results Are in: Pfizer’s Clinical Trial with Young Adults

AP Photo/Mark Lennihan

It's possible that teens and pre-teens may be able to go back to school this fall vaccinated. Pfizer has released the results of clinical trial on young adults aged 12 to 15. Albeit it was a small study, but it was extremely successful. As in 100 percent successful. 

Advertisement

In a study of 2,260 volunteers, "preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots," Pfizer reported, according to the Associated Press.

The subjects experienced the same side effects as adults, including pain, fever, chills and fatigue.

"We share the urgency to expand the use of our vaccine,” Pfizer CEO Albert Bourla said in a statement. He expressed “the hope of starting to vaccinate this age group before the start of the next school year” in the United States. 

Advertisement

As of now, Pfizer is only approved for individuals 16 and up.

With the encouraging results, Pfizer and BioNTech plan to ask the Food and Drug Administration for approval within the coming weeks.

There are currently three FDA approved coronavirus vaccines: Pfizer-BioNTech, Moderna and Johnson & Johnson. J&J is the only one that requires only one dose. 

Moderna is also planning to conduct a study of 12 to 17-year-olds.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement